Correlation Between Crispr Therapeutics and Prime Medicine,
Can any of the company-specific risk be diversified away by investing in both Crispr Therapeutics and Prime Medicine, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crispr Therapeutics and Prime Medicine, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crispr Therapeutics AG and Prime Medicine, Common, you can compare the effects of market volatilities on Crispr Therapeutics and Prime Medicine, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crispr Therapeutics with a short position of Prime Medicine,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crispr Therapeutics and Prime Medicine,.
Diversification Opportunities for Crispr Therapeutics and Prime Medicine,
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Crispr and Prime is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Crispr Therapeutics AG and Prime Medicine, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prime Medicine, Common and Crispr Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crispr Therapeutics AG are associated (or correlated) with Prime Medicine,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prime Medicine, Common has no effect on the direction of Crispr Therapeutics i.e., Crispr Therapeutics and Prime Medicine, go up and down completely randomly.
Pair Corralation between Crispr Therapeutics and Prime Medicine,
Given the investment horizon of 90 days Crispr Therapeutics AG is expected to generate 0.55 times more return on investment than Prime Medicine,. However, Crispr Therapeutics AG is 1.83 times less risky than Prime Medicine,. It trades about 0.13 of its potential returns per unit of risk. Prime Medicine, Common is currently generating about 0.02 per unit of risk. If you would invest 3,936 in Crispr Therapeutics AG on November 1, 2024 and sell it today you would earn a total of 268.00 from holding Crispr Therapeutics AG or generate 6.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crispr Therapeutics AG vs. Prime Medicine, Common
Performance |
| Timeline |
| Crispr Therapeutics |
| Prime Medicine, Common |
Crispr Therapeutics and Prime Medicine, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crispr Therapeutics and Prime Medicine,
The main advantage of trading using opposite Crispr Therapeutics and Prime Medicine, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crispr Therapeutics position performs unexpectedly, Prime Medicine, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prime Medicine, will offset losses from the drop in Prime Medicine,'s long position.| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
| Prime Medicine, vs. Beam Therapeutics | Prime Medicine, vs. Caribou Biosciences | Prime Medicine, vs. Intellia Therapeutics | Prime Medicine, vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |